Gary Remington
Department of Psychiatry
University of Toronto
Toronto
Canada
Name/email consistency: high
- Tetrabenazine augmentation in treatment-resistant schizophrenia: a 12-week, double-blind, placebo-controlled trial. Remington, G., Kapur, S., Foussias, G., Agid, O., Mann, S., Borlido, C., Richards, S., Javaid, N. J. Clin. Psychopharmacol (2012)
- Schizophrenia as a disorder of too little dopamine: implications for symptoms and treatment. Remington, G., Agid, O., Foussias, G. Expert. Rev. Neurother (2011)
- Progress in defining optimal treatment outcome in schizophrenia. Remington, G., Foussias, G., Agid, O. CNS. Drugs (2010)
- Alterations of dopamine and serotonin transmission in schizophrenia. Remington, G. Prog. Brain Res. (2008)
- Tardive dyskinesia: eliminated, forgotten, or overshadowed? Remington, G. Curr. Opin. Psychiatry (2007)
- The use of electronic monitoring (MEMS) to evaluate antipsychotic compliance in outpatients with schizophrenia. Remington, G., Kwon, J., Collins, A., Laporte, D., Mann, S., Christensen, B. Schizophr. Res. (2007)
- A PET study evaluating dopamine D2 receptor occupancy for long-acting injectable risperidone. Remington, G., Mamo, D., Labelle, A., Reiss, J., Shammi, C., Mannaert, E., Mann, S., Kapur, S. Am. J. Psychiatry (2006)
- The crossover approach to switching antipsychotics: what is the evidence?. Remington, G., Chue, P., Stip, E., Kopala, L., Girard, T., Christensen, B. Schizophr. Res. (2005)
- Rational pharmacotherapy in early psychosis. Remington, G. Br. J. Psychiatry. Suppl (2005)
- Augmentation strategies in clozapine-resistant schizophrenia. Remington, G., Saha, A., Chong, S.A., Shammi, C. CNS. Drugs (2005)
- The use of pharmacotherapy in the prodrome of schizophrenia. Remington, G., Shammi, C. CNS. Spectr (2004)
- Understanding antipsychotic "atypicality": a clinical and pharmacological moving target. Remington, G. J. Psychiatry. Neurosci (2003)
- 'Atypical' antipsychotics: where does ziprasidone fit?. Remington, G. Expert. Rev. Neurother (2002)
- Antipsychotic dosing patterns for schizophrenia in three treatment settings. Remington, G., Shammi, C.M., Sethna, R., Lawrence, R. Psychiatr. Serv (2001)
- Clomipramine versus haloperidol in the treatment of autistic disorder: a double-blind, placebo-controlled, crossover study. Remington, G., Sloman, L., Konstantareas, M., Parker, K., Gow, R. J. Clin. Psychopharmacol (2001)
- SB-277011 GlaxoSmithKline. Remington, G., Kapur, S. Curr. Opin. Investig. Drugs (2001)